Greenitio
Entrepreneur First '21Singapore, SG · Founded 2021 · 3 known investors
Greenitio develops bio-based specialty ingredients that replace petrochemical and microplastic-based materials in cosmetics and personal care, using a patented green chemistry platform to convert natural polymers into biodegradable alternatives. Its materials target functions such as SPF boosting, texture, and stability, and address the EU's upcoming ban on intentionally added microplastics.
Also known as Greenitio Pte Ltd
Founders & leadership
Greenitio was founded in 2021 by Amit Khan, Susmita Roy, and Paul Ceralde.
Investors · 3
Company profile
researched Aug 2026Greenitio is a Singapore-based materials technology company that develops functional, tunable biopolymers as direct replacements for microplastic- and petrochemical-derived ingredients in cosmetics, personal care, home care and specialty chemical applications. Its patented green chemistry platform selectively modifies functional groups on naturally derived polymers—primarily fungal (mushroom-derived) chitosan—to tune properties such as water compatibility, hydrophobic interaction, film formation, moisturisation, surface adhesion, conditioning, dispersion, suspension and emulsion stabilisation. The company describes an application-driven development approach in which formulation challenges are identified first and polymer functionality is engineered around them.
The commercial portfolio is organised into branded families for personal care. Chitosola (grades Aqua, Aqua HLP, Boost, Boost HLP) is positioned as an SPF-boosting platform for organic, hybrid and mineral sunscreen systems, supporting UV-filter and pigment dispersion, uniform film formation and emulsion stability; the company states SPF uplift has been validated through in-vivo testing in finished sunscreen formulations. Chitogum and Chitogum Clear are hydrophobically modified flexible film formers for hair care and multifunctional formulation roles such as conditioning, anti-frizz, deposition, co-emulsification and suspension. Chitobe is a water-soluble cationic polymer for breathable moisturising films and conditioning, while Chitobela LipoGel is a hydrophobically modified, water-dispersible cationic biopolymer for deep moisturisation with claimed antimicrobial, anti-acne and anti-ageing bioactivity. A microencapsulation platform for protecting and controlling deposition or release of fragrance and other actives is described as in development.
Personal care—sun care, skin care and hair care—is presented as the initial market and proving ground, with the same chemistry platform positioned for later application in food and coatings, packaging and films, agriculture and other advanced bio-based materials.
Business model
Greenitio develops and supplies functional biopolymer ingredients to formulators and manufacturers in cosmetics, personal care, home care and specialty chemicals. It offers both fully-certified off-the-shelf additives and bespoke formulations, and provides technical/formulation support to help customers select grades and evaluate performance in their own systems. A microencapsulation platform is offered as a collaborative development project rather than a finished product.
Sale of specialty ingredient materials—off-the-shelf certified additives and bespoke/custom-developed formulations—to cosmetics, personal care, home care and specialty chemical customers, supported by collaborative development projects such as the encapsulation platform.
Traction
Three flagship biopolymer lines (Chitosola, Chitobe, Chitobela) are listed in INCI and registered with China's IECIC; SPF-boosting performance has been validated in-vivo in finished sunscreen formulations. The company operates an integrated R&D and pilot facility in Singapore, reports several additional materials moving from R&D into pilot production to meet commercial demand, and raised a US$1.5 million Seed round in September 2025.
Latest developments
On 5 September 2025 Greenitio announced a US$1.5 million Seed round led by SGInnovate with participation from Better Bite Ventures, Silverstrand Capital and existing investors and angels from the chemicals and cosmetics industries. The company said the funding would take it from lab-scale proof to real-world deployment by scaling manufacturing, advancing regulatory approvals and expanding commercial partnerships, and that it would set up a Benelux subsidiary for Europe. Several additional materials were described as transitioning from R&D into pilot production, and the microencapsulation platform remains in development.
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
Positioned as an early-commercialisation materials technology supplier of bio-based functional ingredients targeting the substitution of microplastic- and petrochemical-derived polymers in cosmetics and specialty chemicals. As of the September 2025 Seed announcement the company described itself as moving from lab-scale proof toward commercial readiness, with three flagship lines regulatory-listed and other materials entering pilot production.
The company frames its approach as engineering better-performing materials from renewable starting points rather than substituting a natural alternative at lower performance. Claimed differentiators include a proprietary, patented water-based functionalisation process that eliminates chemical waste and lowers carbon footprint by up to 87% versus conventional chemistry, roughly three times the cost-efficiency of comparable bio-based alternative ingredients, cationic and tunable polymers compatible with water-soluble, oil-dispersible and emulsion systems, in-vivo validated SPF boosting, INCI listing and China IECIC registration of its flagship lines, and an established manufacturing pathway in India.
Technology
A proprietary, patented water-based green chemistry functionalisation platform that selectively modifies functional groups on naturally derived polymers, principally fungal/mushroom-derived chitosan. The process is described as eliminating chemical waste, lowering carbon footprint by up to 87% versus conventional chemistry and delivering about three times the cost-efficiency of comparable bio-based alternatives. It yields cationic, tunable polymers that can be incorporated into water-soluble, oil-dispersible and emulsion-compatible systems, generating distinct material architectures: hydrophilic functional polymers, hydrophobically modified polymers, functional film-forming systems and encapsulation systems.
Go-to-market
Greenitio sells through direct technical engagement with formulators: its site invites sample and technical data sheet (TDS) requests for each grade and offers a technical team to recommend starting materials and evaluation approaches. Post-Seed priorities include expanding commercial partnerships with global cosmetics and chemical companies and establishing a European hub in Benelux. Regulatory listings (INCI, China IECIC) support customer adoption.
Cosmetics, personal care and home care brands and contract manufacturers—particularly sun care, skin care and hair care formulators—plus specialty chemical companies; the platform is also positioned for future customers in food and coatings, packaging and films, and agriculture.
Geography
Headquartered in Singapore, where it operates an integrated R&D and pilot facility covering product development from molecule design to application testing. It cites an established manufacturing pathway in India and, as of September 2025, announced plans for a dedicated subsidiary in Benelux to support European customer collaborations and commercial scale-up. It states it works with brands and manufacturers worldwide and builds for international regulatory requirements.
History
The company was founded in 2021 in Singapore. It built a patented water-based green chemistry process for converting fungal-derived chitosan into functional biopolymers, established an integrated R&D and pilot facility in Singapore covering molecule design through application testing, and secured INCI listings and China IECIC registrations for its Chitosola, Chitobe and Chitobela lines. In September 2025 it announced a US$1.5 million Seed round led by SGInnovate, alongside plans to scale manufacturing, advance regulatory approvals, expand commercial partnerships and open a Benelux subsidiary for Europe.
Risks & controversies
Available sources note the company is still moving from lab-scale proof to real-world deployment, with several materials only transitioning from R&D into pilot production and the microencapsulation platform still in development, indicating execution and scale-up risk. Performance and sustainability claims (87% carbon footprint reduction, ~3x cost-efficiency, bioactivity claims) originate from the company and its investor's press release and are not independently verified in the sources reviewed.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 3
launches, deals, and filingsCompany stated it will establish a dedicated subsidiary in Benelux to support customer collaborations and commercial scale-up across Europe.
Seed round of US$1.5 million led by SGInnovate with participation from Better Bite Ventures, Silverstrand Capital, and existing investors and angels from the chemicals and cosmetics industries; proceeds earmarked for scaling manufacturing, advancing regulatory approvals and expanding commercial partnerships.
$1.5M source ↗
All three flagship biopolymer lines are listed in the International Nomenclature of Cosmetic Ingredients (INCI) and registered with the Inventory of Existing Cosmetic Ingredients in China (IECIC).
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 8
primary sources listed
- Greenitiogreenitio.com · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Greenitio do?
- Singapore materials startup turning fungal chitosan into functional biopolymers that replace microplastic and petrochemical cosmetic ingredients.
- Who founded Greenitio?
- Greenitio was founded by Amit Khan, Susmita Roy, Paul Ceralde in 2021.
- Who are Greenitio's investors?
- Greenitio's investors include Better Bite Ventures, Entrepreneur First, Silverstrand Capital.
- Where is Greenitio headquartered?
- Greenitio is headquartered in Singapore, SG.